Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Carcinoma

Explore clinical trials studying Primary Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.

102 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Carcinoma trial results

Not Yet Recruiting

Surgery for Relapsed Ovarian Cancer in Precision

NCT06602063

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Zhongshan Hospital Fudan University Shanghai, China
  • Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, China
View Trial Details
Not Yet Recruiting

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

NCT04515602

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China
  • Obstetrics & Gynecology Hospital of Fundan University Shanghai, China
  • Shanghai First Maternity and Infant Hospital Shanghai, China
  • Shanghai Jiao Tong University School of Medicine Xinhua Hospital Shanghai, China
View Trial Details
Completed

Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study

NCT06274541

Conditions
Adnexal Diseases, Endometrioid Carcinoma Ovary, Fallopian Tube Cancer, +13 more
Locations
  • Mater Misericordiae University Hospital / Mater Private Hospital Dublin, Leinster, Ireland
  • St James's Hospital Dublin, Leinster, Ireland
  • Bon Secours Cork, Munster, Ireland
  • Cork University Hospital Cork, Munster, Ireland
View Trial Details
Completed

A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

NCT05198804

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Arizona Oncology Associates (Wilmot HOPE) - USOR Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 22 locations
View Trial Details
Completed

Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

NCT05483933

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations
  • University of Arkansas for Medical sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 21 locations
View Trial Details
Completed

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

NCT03748186

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Arizona Oncology - Tucson Tucson, Arizona, United States
  • UCLA Jonsson Comprehensive Cancer Center Clinical Research Unit Los Angeles, California, United States
  • Sutter Health- Palo Alto Medical Foundation San Francisco, California, United States
  • Rocky Mountain Cancer Center Aurora, Colorado, United States
View all 27 locations
View Trial Details
Completed

A Study of CDX-585 in Patients With Advanced Malignancies

NCT05788484

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +64 more
Locations
  • George Washington University Cancer Center Washington D.C., District of Columbia, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • Perlmutter Cancer Center at NYU Langone Health New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer

NCT03783949

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Medical University of Innsbruck Innsbruck, Austria
  • UZLeuven Leuven, Vlaams-Brabant, Belgium
  • Centre de lutte contre le cancer Francois Baclesse Caen, France
  • Centre anticancereux Leon Berard Lyon, France
View all 13 locations
View Trial Details

Related conditions